Kratom
Also called Mitragyna Speciosa, กระท่อม (Thai), Ketum, Kratum
Dosage
Oral bands as drawn from PsychonautWiki's ranges below. The table is the source of truth.
When sources disagree, both rows are shown as published. Nothing is averaged or merged.
Oral
| Source | Threshold | Light | Common | Strong | Heavy |
|---|---|---|---|---|---|
| PsychonautWiki | 1 g PW | 2–3 g PW | 3–5 g PW | 5–8 g PW | 8 g+ PW |
| TripSit | – | 0.5–1.5 g TS | 1.5–3 g TS | 3–6 g TS | – |
Note: This is for plain leaf only. Some users experience stronger effects from lower doses compared to higher doses. It also is very different person to person, just use this as an outline, as it will change batch to batch and even dose to dose. TS
TripSit dose text
TripSit's factsheet also states its doses as text.
Light: 0.5-1.5g Common: 1.5-3g Strong: 3-6g | Note: This is for plain leaf only. Some users experience stronger effects from lower doses compared to higher doses. It also is very different person to person, just use this as an outline, as it will change batch to batch and even dose to dose. TS
What dose are you on? (self-reported, unverified)
No reports yet.
Reports are anonymous, one per browser per day per route. Counts under 20 are shown but marked as too few to mean anything. Until accounts launch, reports stay in this browser only.
Duration
Oral, drawn at the midpoint of each PsychonautWiki range.
| Route · source | Onset | Come-up | Peak | Offset | Total | After-effects |
|---|---|---|---|---|---|---|
| Oral · PsychonautWiki | 20–40 minutes PW | – | 1–3 hours PW | 2–4 hours PW | 3–7 hours PW | – |
TripSit factsheet
Mixing
For best safety practice, don't mix this drug with other depressants.
Why: respiratory depression. PsychonautWiki says:
- “Respiratory depression (also known as hypoventilation) can be described as a reduced urge to breathe that can be fatal depending on its intensity.” (PsychonautWiki, Respiratory depression, revision 150612)
- “... otherwise safe dosages of these compounds can become fatal when combined with even small amounts of other classes of depressant. For example, benzodiazepines combined with opioids are an extremely common cause of fatal respiratory depression. It is therefore strongly discouraged to combine these depressants at any dosage range.” (PsychonautWiki, Respiratory depression, revision 150612)
- “The most common cause of substance-related deaths is the combination of depressants (such as opiates, benzodiazepines, or alcohol) with other depressants.” (PsychonautWiki, Responsible drug use, revision 168206)
- “This combination potentiates the muscle relaxation, amnesia, sedation, and respiratory depression caused by one another. At higher doses, it can lead to a sudden, unexpected loss of consciousness along with a dangerous amount of depressed respiration.” (PsychonautWiki, dangerous interactions table, "Depressants" row, revision 156847)
For best safety practice, don't mix this drug with other stimulants.
Why: vasoconstriction, heart rate and blood pressure. PsychonautWiki says:
- “... may be dangerous to combine with other stimulants ... as they can increase one's heart rate and blood pressure to dangerous levels.” (PsychonautWiki, dangerous interactions table, "Stimulants" row, revision 148925)
- “Vasoconstriction can be described as a narrowing of the veins and blood vessels which results from a contraction of their muscular wall.” (PsychonautWiki, Vasoconstriction, revision 170337)
- “... it can also occur under the influence of traditional stimulants such as methamphetamine, caffeine, and MDMA.” (PsychonautWiki, Vasoconstriction, revision 170337)
- “Increased blood pressure is most commonly induced under the influence of heavy dosages of vasoconstricting compounds, such as traditional stimulants and stimulating psychedelics.” (PsychonautWiki, Increased blood pressure, revision 152273)
Quotes from PsychonautWiki, CC BY-SA 4.0.
Acute combinations: what happens when these are taken close together. Entries backed by a medical journal or agency are listed first.
Backed by medical journals
PsychonautWiki also lists dangerous combinations shared across a whole group (opioids) in a table this page does not copy. Read that list on PsychonautWiki.
TripSit combination chart
TripSit rates each pairing. Only pairings with a number carry a citation from TripSit. See the whole chart; TripSit's own notes are on combo.tripsit.me.
Risks and toxicity
Kratom has a low toxicity relative to dose. Like most opioids, safe usage of kratom is not known to cause any dangerous long-term complications. Heavy dosages of kratom can result in increased respiratory depression, leading onto fatal or dangerous levels of anoxia (oxygen deprivation). This is significantly less powerful than the respiratory depression of heroin or morphine. This occurs because the breathing reflex is suppressed by agonism of µ-opioid receptors proportional to the dosage consumed. PW
It is likely impossible to achieve this using kratom in its standard leaf form as the nausea ceiling makes it difficult to consume high enough dosages without vomiting. A pure extract or tincture, however, may be potent enough to cause lethal respiratory depression at appropriate dosages, although oral administration of pure mitragynine to mice in dosages up to 920 mg/kg did not produce lethal respiratory depression. However, kratom can be fatal when it is combined with other depressants such as alcohol or benzodiazepines.[4] PW
Side effects associated with chronic kratom use include loss of appetite and weight loss, constipation, decreased libido, apathy, and darkening of the skin color of the face. Chronic use has been associated with bowel obstruction.[5]
It is strongly recommended that one use harm reduction practices when using this substance. PW
Lethal dosage
The lethal dosage of kratom is unknown but thought to be far above the active dosage. The precise dosage likely depends on a variety of factors including strain, potency, tolerance and method of consumption. It is unlikely that one could ingest a lethal dosage of kratom powder as the nausea will force one to vomit at around 8 - 9 grams; however, it could be possible to ingest a lethal dosage of a kratom if purer forms such as a resin or pure alkaloids are used. PW
Three case reports document deaths involving kratom. Other drugs were used in all cases, and in one, kratom was speculated to possibly be the primary cause of death. O-Desmethyltramadol (ODSMT) was present in the latter case, and has been found to be a frequent additive in certain commercial brands of kratom, there were nine cases of death reported in Sweden in 2010 and 2011 relating to use of Krypton, which was kratom mixed with O-Desmethyltramadol.[7–10] PW
Dependence and abuse potential
As with other opioids, the kratom produces dependence with chronic use and has a high abuse potential. When dependence has developed, cravings and withdrawal symptoms may occur if a person suddenly stops their usage.[10] PW
Tolerance to many of the effects of kratom develops with prolonged and repeated use. The rate at which this occurs develops at different rates for different effects, with tolerance to the constipation-inducing effects developing particularly slowly for instance. This results in users having to administer increasingly large doses to achieve the same effects. After that, it takes about 3 - 7 days for the tolerance to be reduced to half and 1 - 2 weeks to be back at baseline (in the absence of further consumption). Kratom presents cross-tolerance with all other opioids, meaning that after the consumption of kratom all opioids will have a reduced effect. PW
Chronic kratom use may lead to tolerance to the effects of serotonergic psychedelics due to kratom's antagonism of the 5-HT2A receptor and said receptor's paradoxical down-regulation in response to inhibitors.[11]
Since kratom is classified as an herbal supplement and remains legal in many states, a subset of individuals mistakenly assume that it can be used regularly and eventually discontinued without any withdrawal symptoms. In reality, most individuals who use kratom on a regular basis will experience some withdrawal symptoms following cessation.[13] PW
Testing
- Detection
- Kratom use is not detected by typical drug screening tests, but its metabolites can be detected by more specialized testing. TS
Effects
Simultaneous stimulation & sedationFeelings of empathyFeelings of euphoriaAphrodisiac qualities for some peopleVivid waking dreamsUseful with physical labor TS
Overview
Mitragyna speciosa (also known as kratom) is a tropical tree of the coffee family indigenous to South East Asia. The leaves of M. speciosa contain various psychoactive alkaloids that produce mild stimulant and opioid effects. The pharmacology of kratom is complex, although it produces its major effects through action at opioid receptors in the brain.[1] PW
A drug made out of the leaves of Mitragyna Speciosa, which is related to coffee. Stimulating at lower doses, with opioid effects at higher doses. Frequent heavy use can cause physical addiction and withdrawals.[2]
In a 2023–24 US online survey, everyone who said they had ever used akuamma seed had also tried kratom. PubMed
History
Legal status
- Australia: As of January 2015, kratom is a controlled and prohibited narcotic substance which requires a permit and license to import into the country.[14] PW
- Canada: As of October 2016, it is illegal to market kratom for any use in which it is ingested. However, kratom may be marketed for other uses, such as incense.[15] PW
- Europe: As of September 2011, kratom, mitragynine, and 7-hydroxymitragynine are controlled substances in a number of EU Member States such as Denmark, Latvia, Lithuania, Poland, Romania and Sweden.[16] PW
- Germany: Kratom is not a controlled substance under the BtMG. It is legal, as long as it is not sold for human consumption, according to §2 AMG. This legal opinion was approved by court descision of the OLG Köln (Higher Regional Court Cologne), as of September 11, 2015.[17]
[18] [19] PW - Japan: Kratom and its active constituents mitragynine and 7-hydroxymitragynine are controlled substances in Japan effective March 9th, 2016.[20] PW
- Latvia: Kratom and its primary active constituent mitragynine are Schedule I controlled substances according to an amendment on August 16th, 2012.[21] PW
- Malaysia: The use of kratom leaves is prohibited in Malaysia under Section 30 (3) Poisons Act 1952, and the user may be, penalized with a maximum compound of MYR 10,000 (USD 3,150) or up to 4 years imprisonment.[22] PW
- New Zealand: Kratom and its primary active constituent mitragynine, after an amendment on August 6, 2015, are Schedule I controlled substances under Medicines Regulations 1984[23] PW
- Switzerland: Mitragynine and 7-Hydroxymitragynine are controlled substances specifically named under Verzeichnis A.[24] PW
- Thailand: Possession of kratom leaves is illegal in Thailand, despite the tree being native to the country. The Thai government passed the kratom Act 2486 which made planting the tree illegal and requires existing trees to be cut down. As of October 2, 2013, the justice ministry of Thailand suggested removal of kratom from the narcotic drug list relating to Category 5 of the Narcotic Drug Law of 1979, though still recommended regulating kratom in other ways.[25] PW
- Turkey: Kratom is a classed as drug and is illegal to possess, produce, supply, or import.[26]
[27] PW - United Kingdom: It is illegal to produce, supply, or import this drug under the Psychoactive Substance Act, which came into effect on May 26th, 2016.[28] PW
- United States: On August 31, 2016, the DEA issued a statement indicating its intention to place kratom on Schedule I of the U.S. Controlled Substances Act in the temporary scheduling category. This ban would have come into effect on September 30th, 2016, but was withdrawn on October 13th, 2016. A public comment period, which closed on December 1st, 2016. Following the comment period, the DEA will have to issue a new statement of intent to place kratom in Schedule I. While there are states that have pledged to not pursue legislation to ban kratom, many others have passed or have pending legislation to ban kratom. It is currently prohibited in the states of Tennessee, Rhode Island, Vermont, Arkansas, Indiana, and Wisconsin.[29]
[30] [31] PW - Netherlands: Kratom is legal to possess, buy, and sell in the Netherlands according to the Opium Act of May 12th, 1928.[32] PW
Pharmacology
Chemistry
User reports
Erowid erowid.org
ListingsErowid Experience Vault listing
Link as published on TripSit's factsheet.
Top storiesBluelight bluelight.org
ListingsReddit reddit.com
ListingsPop culture
No references added yet.
Add a reference
Registered users can add songs, films, books, shows, games and art about this substance. Link a source that names the substance, such as the work's Wikipedia article, a review or an interview, not only the work itself. Entries are voted on and moderated like every other value on this page.
Opens when accounts launch.
References
- Journal / agency Kruegel, A. C., Grundmann, O. The medicinal chemistry and neuropharmacology of kratom: A preliminary discussion of a promising medicinal plant and analysis of its potential for abuse. Neuropharmacology. May 2018. doi:10.1016/j.neuropharm.2017.08.026
- Journal / agency Seizure and coma following Kratom (Mitragynina speciosa Korth) exposure
- Journal / agency A drug toxicity death involving propylhexedrine and mitragynine
- Other Raffa, R. B. Kratom and Other Mitragynines: The Chemistry and Pharmacology of Opioids from a Non-Opium Source. 29 October 2014
- Journal / agency Adkins, J. E., Boyer, E. W., McCurdy, C. R. Mitragyna speciosa, a psychoactive tree from Southeast Asia with opioid activity. Current Topics in Medicinal Chemistry. 2011. doi:10.2174/156802611795371305
- Journal / agency Hassan, Z., Muzaimi, M., Navaratnam, V., Yusoff, N. H. M., Suhaimi, F. W., Vadivelu, R., Vicknasingam, B. K., Amato, D., Hörsten, S. von, Ismail, N. I. W., Jayabalan, N., Hazim, A. I., Mansor, S. M., Müller, C. P. From Kratom to mitragynine and its derivatives: physiological and behavioural effects related to use, abuse, and addiction. Neuroscience and Biobehavioral Reviews. February 2013. doi:10.1016/j.neubiorev.2012.11.012
- Journal / agency Neerman, M. F., Frost, R. E., Deking, J. A drug fatality involving Kratom. Journal of Forensic Sciences. January 2013. doi:10.1111/1556-4029.12009
- Journal / agency Holler, J. M., Vorce, S. P., McDonough-Bender, P. C., Magluilo, J., Solomon, C. J., Levine, B. A drug toxicity death involving propylhexedrine and mitragynine. Journal of Analytical Toxicology. January 2011. doi:10.1093/anatox/35.1.54
- Journal / agency Kronstrand, R., Roman, M., Thelander, G., Eriksson, A. Unintentional fatal intoxications with mitragynine and O-desmethyltramadol from the herbal blend Krypton. Journal of Analytical Toxicology. May 2011. doi:10.1093/anatox/35.4.242
- Journal / agency Rosenbaum CD, Carreiro SP, Babu KM. Here today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines. Journal of Medical Toxicology. 2012. doi:10.1007/s13181-011-0202-2 · PMID 22271566 · PMC3550220
- Journal / agency Warner, M. L., Kaufman, N. C., Grundmann, O. The pharmacology and toxicology of kratom: from traditional herb to drug of abuse. International Journal of Legal Medicine. January 2016. doi:10.1007/s00414-015-1279-y
- Journal / agency Van Oekelen, D., Luyten, W. H. M. L., Leysen, J. E. 5-HT2A and 5-HT2C receptors and their atypical regulation properties. Life Sciences. April 2003. doi:10.1016/S0024-3205(03)00141-3
- Other Kratom Withdrawal Symptoms. 2017
- Other List of Prohibited Substances in Australia. 2022
- Other After U.S. delayed decision on kratom, a look at Canada’s laws on the psychadelic plant
- Harm reduction site http://www.emcdda.europa.eu/publications/drug-profiles/kratom#control
- Other Anlage I BtMG - Einzelnorm
- Other § 2 AMG - Einzelnorm
- Other https://openjur.de/u/866755.html
- Other 危険ドラッグの成分5物質及び1植物種を新たに指定薬物に指定
- Other Zaudējis spēku - Noteikumi par Latvijā kontrolējamajām narkotiskajām vielām, psihotropajām vielām un prekursoriem
- Other Utusan Malaysia: Pinda akta daun ketum kepada Akta Dadah Berbahaya
- Other Medicines Regulations 1984 (SR 1984/143) (as at 01 July 2022) Schedule 1 Prescription, restricted, and pharmacy-only medicines – New Zealand Legislation
- Other Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien
- Other Kratom in Thailand: Decriminalization and Community Control?
- Other Başbakanlık Mevzuatı Geliştirme ve Yayın Genel Müdürlüğü
- Other https://resmigazete.gov.tr/eskiler/2014/01/20140125-3-1.pdf
- Other Psychoactive Substances Act 2016
- Other Schedules of Controlled Substances: Temporary Placement of Mitragynine and 7-Hydroxymitragynine into Schedule I (Drug Enforcement Agency)
- Other Withdrawal of Notice of Intent to Temporarily Place Mitragynine and 7-Hydroxymitragynine Into Schedule I. 2016
- Other Indiana HB1196, 2012, Regular Session
- Other Koninkrijksrelaties, M. van B. Z. en. Opiumwet
Text and values on this page are quoted from PsychonautWiki (CC BY-SA 4.0), TripSit factsheets. Each value links to the exact revision it came from.